Wikisage, the free encyclopedia of the second generation, is digital heritage
Neurocysticercosis: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
(type err) |
||
| Line 1: | Line 1: | ||
Neurocystecercosis is a contributor of late onset [[epilepsy]]<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340353/pdf/pntd.0005153.pdf</ref> | Neurocystecercosis is a contributor of late onset [[epilepsy]]<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340353/pdf/pntd.0005153.pdf</ref> | ||
{{disease|B 69.0| | {{disease|B 69.0|neurocysticercosis}} | ||
<big>Several studies have reported an association between epilepsy and NC based on positive serum antibodies against Taenia solium, which has distorted the perception of the epidemiology of epilepsy related to NC. Immunoserologic assays, such as enzyme-linked immunoelectrotransfer blot assay (EITB) or enzyme-linked immunosorbent assay (ELISA), detect antibodies against T. solium | <big>Several studies have reported an association between epilepsy and NC based on positive serum antibodies against Taenia solium, which has distorted the perception of the epidemiology of epilepsy related to NC. Immunoserologic assays, such as enzyme-linked immunoelectrotransfer blot assay (EITB) or enzyme-linked immunosorbent assay (ELISA), detect antibodies against T. solium | ||
</big> | </big> | ||
Revision as of 18:43, 23 March 2017
Neurocystecercosis is a contributor of late onset epilepsy[1]
Disease classification WHO
B 69.0 neurocysticercosis
Several studies have reported an association between epilepsy and NC based on positive serum antibodies against Taenia solium, which has distorted the perception of the epidemiology of epilepsy related to NC. Immunoserologic assays, such as enzyme-linked immunoelectrotransfer blot assay (EITB) or enzyme-linked immunosorbent assay (ELISA), detect antibodies against T. solium
Weblinks
